Skip to content

statistics

Placebos for all, or why the p-value should have no place in healthcare decision making

David Colquhoun, professor of pharmacology at UCL, has a new essay over at Aeon opining about the problems with p-values. A short while back, we also discussed p-value problems, and Colquhoun arrives at the same conclusions as us about the… Read More »Placebos for all, or why the p-value should have no place in healthcare decision making

Does political reform really reduce child mortality?

Measuring causal effects is a tricky business. But, it’s necessary if we want to appropriately design effective policies and interventions. Many things are not amenable to manipulation in an experiment and so we rely upon a toolbox of statistical tools… Read More »Does political reform really reduce child mortality?

Identifying the effect of expenditure on health outcomes: another small comment on Claxton et al

In a previous post I asked whether the study by Claxton et al can or should inform the cost-effectiveness threshold used by NICE. The authors argued that, “it is the expected health effects … of the average displacement within the… Read More »Identifying the effect of expenditure on health outcomes: another small comment on Claxton et al

Is there any use in publishing surgeons’ death rates?

Today sees the publication of surgeons’ death rates on the MyNHS website (see Guardian and BBC stories). The website presents full lists of surgeons by specialty alongside either blue circles with a large ‘OK’ inside, grey circles with question marks, or… Read More »Is there any use in publishing surgeons’ death rates?